You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Details for Patent: 11,020,377


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,020,377 protect, and when does it expire?

Patent 11,020,377 protects SOLOSEC and is included in one NDA.

This patent has sixteen patent family members in five countries.

Summary for Patent: 11,020,377
Title:Secnidazole for use in the treatment of bacterial vaginosis
Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
Inventor(s): Pentikis; Helen S. (Timonium, MD), Palling; David (Glen Ridge, NJ), Braun; Carol J. (Ellicott City, MD)
Assignee: LUPIN INC. (Baltimore, MD)
Application Number:16/586,372
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,020,377: A Comprehensive Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 11,020,377, it is crucial to delve into the details of its scope, claims, and the broader patent landscape. This analysis will help in understanding the patent's significance, its protection, and its implications for competitors and innovators.

What is a Patent?

A patent is a form of intellectual property that grants the patent holder the exclusive right to make, use, and sell an invention for a specified period, typically 20 years from the filing date. Patents are granted by the U.S. Patent and Trademark Office (USPTO) after a thorough examination process to ensure the invention meets the criteria of novelty, non-obviousness, and usefulness[4].

Patent 11,020,377: Overview

To analyze Patent 11,020,377, we need to start with its basic bibliographic information. This includes details such as the inventors, applicants, and the correspondence address. This information can be found on the USPTO website by searching for the patent number.

Claims Analysis

Importance of Claims

The claims section of a patent is the most critical part as it defines the scope of the invention. Claims must "particularly point out" and "distinctly claim" the subject matter of the invention, as required by 35 USC 112(b)[2].

Types of Claims

Patent claims can be independent or dependent. Independent claims stand alone and define the invention, while dependent claims refer back to an independent claim and further limit the scope of the invention.

Subjective Claims Terms

When drafting patents, especially those involving subjective terms, it is essential to provide numerous and meaningful examples to ensure clarity. The courts have recognized the need for a "delicate balance" between the inherent limitations of language and providing clear notice of what is claimed[2].

Patent File Wrappers

What is a Patent File Wrapper?

A patent file wrapper, also known as the patent prosecution history, contains all the documents and communications between the patent applicant and the USPTO during the patent application process. This includes office actions, responses, and any amendments made to the claims[1].

Using File Wrappers for Competitive Intelligence

Analyzing the file wrapper of Patent 11,020,377 can provide valuable insights into the patent's history, including any rejections, amendments, and the examiner's arguments. This information can help competitors understand the limitations and strengths of the patent claims[1].

Prior Art and Novelty

Role of Prior Art

The examiner reviews the prior art to determine whether the claims are novel, non-obvious, and useful. If the claims are rejected due to prior art, the applicant may need to narrow or limit the scope of the claims to overcome these rejections[1].

Example from Amazon's Patent

For instance, in the case of Amazon's U.S. Patent No. 9,205,380, the examiner rejected certain claims based on prior art. The applicant had to argue and potentially amend the claims to overcome these rejections, illustrating the importance of prior art in shaping the final claims[1].

Section 101 Eligibility

Subject Matter Eligibility

Patent claims must also meet the subject matter eligibility criteria under Section 101 of the America Invents Act. This involves determining whether the claims are directed to patent-ineligible concepts, such as abstract ideas, and whether the other elements of the claim transform it into patent-eligible subject matter[4].

Impact of Alice Corp. v. CLS Bank International

The Supreme Court's decision in Alice Corp. v. CLS Bank International introduced a two-part test for determining software patent eligibility, which has significantly impacted the patent prosecution process. This test has led to increased rejections based on Section 101, adding complexity to the patent examination process[4].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

To understand the full scope of Patent 11,020,377, a Claim Coverage Matrix can be used. This tool categorizes patents and claims by their scope concepts, helping to identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Interactive Claim Charts

Tools like ClaimScape® software generate interactive claim charts that can be reviewed by technical experts to determine whether a particular scope concept is applicable to a target product or method. These charts help in identifying areas where claim coverage is lacking and highlight future design opportunities[3].

Small Claims Patent Court

Need for a Small Claims Patent Court

There has been a discussion about the need for a small claims patent court to handle disputes involving smaller entities or less complex patent issues. The Administrative Conference of the United States (ACUS) has conducted studies on this topic, engaging with various stakeholders to understand the feasibility and potential structure of such a court[5].

Key Takeaways

  • Claims are Crucial: The claims section of a patent defines its scope and must be clear and distinct.
  • Prior Art: Understanding prior art is essential for determining the novelty and non-obviousness of the invention.
  • Section 101 Eligibility: Claims must meet the subject matter eligibility criteria, which can be complex, especially for software patents.
  • Patent File Wrappers: Analyzing the patent file wrapper provides valuable competitive intelligence.
  • Patent Analytics: Tools like Claim Coverage Matrix and interactive claim charts help in understanding the patent landscape and identifying gaps in coverage.

FAQs

Q: What is the significance of the claims section in a patent? A: The claims section is the most critical part of a patent as it defines the scope of the invention and must "particularly point out" and "distinctly claim" the subject matter.

Q: How does prior art affect the patent application process? A: Prior art is reviewed by the examiner to determine whether the claims are novel, non-obvious, and useful. If the claims are rejected due to prior art, the applicant must amend the claims to overcome these rejections.

Q: What is the impact of the Alice Corp. v. CLS Bank International decision on software patents? A: The decision introduced a two-part test for determining software patent eligibility, leading to increased rejections based on Section 101 and adding complexity to the patent examination process.

Q: What is a Claim Coverage Matrix, and how is it used? A: A Claim Coverage Matrix categorizes patents and claims by their scope concepts, helping to identify which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist.

Q: Why is there a discussion about a small claims patent court? A: The discussion is about creating a court to handle disputes involving smaller entities or less complex patent issues, aiming to make the patent dispute resolution process more accessible and efficient.

Sources

  1. IP Checkups - Patent file wrappers as a tool for competitive intelligence
  2. Buchanan Ingersoll & Rooney PC - Practical Advice for Drafting Patents with Subjective Claims Terms
  3. Schwegman Lundberg & Woessner - Patent Analytics
  4. Von Briesen & Roper, s.c. - USPTO Launches Deferred Approach to Section 101 Eligibility Analysis in Patent Prosecution
  5. Administrative Conference of the United States - U.S. Patent Small Claims Court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,020,377

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Evofem Inc SOLOSEC secnidazole GRANULE;ORAL 209363-001 Sep 15, 2017 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y TREATMENT OF TRICHOMONIASIS IN PATIENTS 12 YEARS OF AGE AND OLDER ⤷  Try for Free
Evofem Inc SOLOSEC secnidazole GRANULE;ORAL 209363-001 Sep 15, 2017 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y TREATMENT OF BACTERIAL VAGINOSIS IN FEMALE PATIENTS 12 YEARS OF AGE AND OLDER ⤷  Try for Free
Evofem Inc SOLOSEC secnidazole GRANULE;ORAL 209363-001 Sep 15, 2017 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y TREATMENT OF TRICHOMONIASIS IN ADULTS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.